"
Team:Freiburg
From 2013.igem.org
(Difference between revisions)
| Line 222: | Line 222: | ||
regulation in mammalian cells. Therefore, we engineered the recently understood and highly promising | regulation in mammalian cells. Therefore, we engineered the recently understood and highly promising | ||
CRISPR/Cas9 system. <br> | CRISPR/Cas9 system. <br> | ||
| - | The regulation is based on the RNA-guided | + | The regulation is based on the RNA-guided dCas9 protein, which allows targeting of specific DNA sequences. |
| - | Our toolkit comprises not only a standardized | + | Our toolkit comprises not only a standardized dCas9 protein, but also different effector domains for |
efficient gene activation or repression. | efficient gene activation or repression. | ||
</div> | </div> | ||
Revision as of 21:40, 15 October 2013
Our Team developed a universal toolkit, termed uniCAS, that enables customizable gene
regulation in mammalian cells. Therefore, we engineered the recently understood and highly promising
CRISPR/Cas9 system.
The regulation is based on the RNA-guided dCas9 protein, which allows targeting of specific DNA sequences. Our toolkit comprises not only a standardized dCas9 protein, but also different effector domains for efficient gene activation or repression. 
|
|
|
|
|
|
|
